Gene · 1022
Papers3,996
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,996
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The p400 complex promotes HIV-1 latency by suppressing viral transcription and altering the host cell state. | Nucleic Acids Res | 2025 | 40842241 | PubTator, text mining | PubMed |
| CDK7 inhibition promotes glioblastoma cell death through convergent transcriptional and metabolic stress pathways. | Clin Transl Med | 2025 | 40836584 | PubTator, text mining | PubMed |
| Unbiased mapping of cereblon neosubstrate landscape by high-throughput proteomics. | Nat Commun | 2025 | 40835825 | PubTator, text mining | PubMed |
| SAGE: A Segment-Anchor-Guided Exploration Framework for the Optimization of CDK7 Inhibitors as Promising Cancer Therapy. | J Phys Chem B | 2025 | 40827953 | PubTator, text mining | PubMed |
| Atypical R-loops in cancer: decoding molecular chaos for therapeutic gain. | J Transl Med | 2025 | 40813661 | PubTator, text mining | PubMed |
| The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia. | Blood Neoplasia | 2025 | 40809193 | PubTator, text mining | PubMed |
| AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells. | Front Immunol | 2025 | 40808939 | PubTator, text mining | PubMed |
| Dual targeting of CDK4/6 and CDK7 augments tumor response and antitumor immunity in breast cancer models. | J Clin Invest | 2025 | 40794455 | PubTator, text mining | PubMed |
| Health is wealth and documents are the currency: exploring the role of NGOs in facilitating healthcare access for undocumented migrants in the Netherlands - a qualitative study. | Int J Equity Health | 2025 | 40790576 | PubTator, text mining | PubMed |
| Trichothiodystrophy-causative pathogenic variants impair a cooperative action of TFIIH and DDX1 in R-loop processing. | Nucleic Acids Res | 2025 | 40757642 | PubTator, text mining | PubMed |
| Sporadic ALS induced pluripotent stem cell derived neurons reveal hallmarks of TDP-43 loss of function. | Nat Commun | 2025 | 40753166 | PubTator, text mining | PubMed |
| New insights into the dule roles CDK12 in human cancers: Mechanisms and interventions for cancer therapy. | J Pharm Anal | 2025 | 40747342 | PubTator, text mining | PubMed |
| The impact of sarcopenia on prognosis and fruquintinib efficacy in advanced colorectal cancer: a retrospective and mendelian randomization study. | Front Immunol | 2025 | 40740773 | PubTator, text mining | PubMed |
| Transcription-Coupled Nucleotide Excision Repair: A Faster Solution or the Only Option? | Biomolecules | 2025 | 40723898 | PubTator, text mining | PubMed |
| Transcription-coupled repair of crosslinking DNA damage. | DNA Repair (Amst) | 2025 | 40706399 | PubTator, text mining | PubMed |
| Targeting CDK2 and other novel cell cycle targets for breast cancer therapy. | Expert Opin Ther Targets | 2025 | 40692275 | PubTator, text mining | PubMed |
| Overcoming Radiotherapy Resistance in Chordoma through the Synergistic Action of Selenium-Containing Nanoparticles and THZ1. | ACS Nano | 2025 | 40674111 | PubTator, text mining | PubMed |
| Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in Chordoma. | JCO Precis Oncol | 2025 | 40601892 | PubTator, text mining | PubMed |
| Targeting CDK7/12/13 functional synergism reverses myofibroblast activation and ameliorates lung fibrosis. | iScience | 2025 | 40585357 | PubTator, text mining | PubMed |
| Multi-omics and biochemical reconstitution reveal CDK7-dependent mechanisms controlling RNA polymerase II function at gene 5'- and 3' ends. | Cell Rep | 2025 | 40570372 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1022/papers?page=6